Discover how treatment adherence impacts the efficacy of modern HIV regimens like DTG/3TC and DTG + TDF/FTC based on the GEMINI clinical trials analysis.
Explore how long-acting cabotegravir and rilpivirine is transforming HIV treatment from daily pills to bimonthly injections, offering new hope and autonomy.
Comparative analysis of Bictegravir and Dolutegravir-based HIV treatments, examining viral suppression, adherence, and long-term outcomes in clinical trials and real-world settings.
Exploring the SATISFACTION study findings on HIV treatment simplification and two-drug regimens versus traditional approaches.
Exploring the scientific showdown between two-drug and three-drug HIV treatment regimens, examining efficacy, safety, and long-term benefits.
Exploring the clinical evidence comparing Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) in HIV treatment through a 96-week randomized switch study.
Discover how dolutegravir and boosted darunavir dual therapy is revolutionizing HIV treatment for highly treatment-experienced individuals with sustained viral suppression.